License

License Not Specified

Other Access

The information on this page (the dataset metadata) is also available in these formats.

JSON RDF

via the DKAN API

A PHASE 2B MULTICENTER RANDOMIZED DOUBLE-BLIND COMPARATIVE TRIAL OF UK-453061 IN COMBINATION WITH TENOFOVIR DF AND EMTRICITABINE VERSUS EFAVIRENZ IN COMBINATION WITH TENOFOVIR DF AND EMTRICITABINE FOR THE TREATMENT OF ANTIRETROVIRAL-NAIVE HIV-1...

The primary objective is to assess efficacy of UK-453061 when used in combination with tenofovir DFemtricitabine as measured by the percentage of subjects with HIV-1 RNA 50 copiesmL at 48 weeks

FieldValue
Modified
2022-01-18
Release Date
2019-05-12
Identifier
050c56b3-c771-4b71-a1b8-1f39d5d4e20f
License
License Not Specified
Public Access Level
Public